Severe acute respiratory syndrome

Clinical Infectious Diseases

Volumn 38, Issue 10, 2004, Pages 1420-1427

  Christian, Michael D ^a   Poutanen, Susan M ^b,c   Loutfy, Mona R ^d   Muller, Matthew P ^b,c   Low, Donald E ^b,c,e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CONSENSUS INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; LOPINAVIR; METHYLPREDNISOLONE; RIBAVIRIN; RITONAVIR;

AVASCULAR NECROSIS; CHINA; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE TRANSMISSION; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LABORATORY TEST; MYCOSIS; PRIORITY JOURNAL; REVIEW; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION;

ANTIVIRAL AGENTS; CHINA; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HUMANS; INFECTION CONTROL; RIBAVIRIN; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 2442691467     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/420743     Document Type: Review

References (69)

1. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 23 September 2003. Available at: http://www.who.int/csr/sars/country/table2003_09_23/en/. Accessed on 25 September 2003.
2. World Health Organization. Biosafety and SARS incident in Singapore September 2003: report of the Review Panel on New SARS Case and Biosafety. Singapore Ministry of Health. 24 September 2003. Available at: http://www.moh.gov.sg/sars/pdf/Report_SARS_Biosafety.pdf. Accessed on 25 September 2003.
3. World Health Organization. SARS: breaking the chains of transmission. 5 July 2003. Available at: http://www.who.int/features/2003/07/en/. Accessed on 5 September 2003.
4. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-66.
5. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
6. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-25.
7. Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362:263-70.
8. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302:276-8.
9. Centers for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:241-8.
10. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003; 361:1761-6.
11. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300: 1966-70.
12. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003; 300:1961-6.
13. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003; 169:285-92.
14. Peiris J, Chu C, Cheng V, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
15. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348:1995-2005.
16. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361:1519-20.
17. Christian MD, Loutfy M, McDonald, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis [serial online] 2004. Available at: http://www.cdc.gov/ncidod/EID/vol10no2/03-0700.htm.
18. World Health Organization. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. 2003. Available at: http://www.who.int/csr/sars/survival_2003_05_04/en/. Accessed on 15 October 2003.
19. World Health Organization. Update 15 - situation in Hong Kong, activities of WHO team in China. 2003. Available at: http://www.who.int/csr/sars/ infectioncontrol/en/. Accessed on 15 October 2003.
20. World Health Organization. Inadequate plumbing systems likely contributed to SARS transmission. 2003. Available at: http://www.who.int/mediacentre/ releases/2003/pr70/en/. Accessed on 15 October 2003.
21. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94.
22. Ofner M, Lem M, Sarwal S, et al. Cluster of severe acute respiratory syndrome cases among protected health care workers - Toronto, April 2003. Can Commun Dis Rep 2003; 29:93-7.
23. Ren Y, Ding HG, Wu QF, et al. Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003; 25:368-71.
24. Centers for Disease Control and Prevention. Severe acute respiratory syndrome - Singapore, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:405-11.
25. Rainer TH, Cameron PA, Smit D, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. Brit Med J 2003; 326:1354-8.
26. Centers for Disease Control and Prevention. Revised US surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases - United States and worldwide, December 2003. MMWR Morb Mortal Wkly Rep 2003; 52:1202-6.
27. World Health Organization. Alert, verification and public health management of SARS in the post-outbreak period. 14 August 2003. Available at: http://www.who.int/csr/sars/postoutbreak/en/. Accessed on 26 April 2004.
28. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289:2801-9.
29. Wong K, Antonio G, Hui D, et al. Think-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology 2003; 228:395-400.
30. Wong K, Antonio G, Hui D, et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003; 228:401-6.
31. Fisher DA, Lim TK, Lim YT, et al. Atypical presentations of SARS. Lancet 2003; 361:1740.
32. Wu EB, Sung JJ. Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS. Lancet 2003; 361:1520-1.
33. Li G, Zhao ZX, Chen LB, et al. Mild severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1182-3.
34. Gold WL, Mederski B, Rose D, et al. Prevalence of asymptomatic (AS) infection by severe acute respiratory syndrome coronavirus (SARS-CoV) in exposed healthcare workers (HCW) [abstract K-1315c]. In: Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
35. Hon K, Leung C, Cheng W, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003; 361: 1701-3.
36. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290:367-73.
37. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290:374-80.
38. Maunder R, Hunter J, Vincent L, et al. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ 2003; 168:1245-51.
39. Styra R, Gold W, Robinson S. Post-traumatic stress disorder and quality of life in patients diagnosed with SARS [abstract V-796a]. In: Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
40. Muller M, Tomlinson G, Marrie T, et al. Discriminatory ability of laboratory parameters in severe acute respiratory syndrome (SARS) [abstract V-796b]. In: Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
41. Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 2003; 349:508-9.
42. Tang P, Louie M, Richardson S, et al. Laboratory diagnosis of severe acute respiratory syndrome (SARS) in Canada [abstract V-485a]. In: Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
43. Hsueh P-R, Hsiao C-H, Yeh S-H, et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003; 9:1163-7.
44. Mahony J, Petrich A, Louie L, et al. Comparison of the cost and performance of seven RT-PCR assays for detecting SARS coronavirus RNA [abstract V-796d]. In: Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
45. Poon LLM, Chan KH, Wong OK, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003; 28:233-8.
46. Chang P, Tam J, Lam C-W, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1058-63.
47. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31:347-82.
48. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-8.
49. Koren G, King S, Knowles S, et al. Ribavirin in the treatment of SARS: a new trick for an old drug? CMAJ 2003; 168:1289-92.
50. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
51. Hsu LY, Lee CC, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003; 9:713-7.
52. Charles M. Severe acute respiratory syndrome (SARS) and coronavirus testing - United States, 2003. The CDC SARS Investigative Team. MMWR Morb Mortal Wkly Rep 2003; 52:297-302.
53. Mazzulli T, Farcas GA, Poutanen SM, et al. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004; 10. Available at: http://www.cdc.gov/ncidod/EID/vol10no1/03-0404.htm. Accessed on 5 April 2004.
54. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
55. Cinatl J, Morgenstern B, Bauer G, et al. Treatment of SARS with human interferons. Lancet 2003; 362:293-4.
56. Loutfy M, Blatt L, Ward S, et al. Preliminary results on the potential therapeutic benefit of interferon alfacon-1 plus steroids in severe acute respiratory syndrome [abstract K-1315e]. In: Program and abstracts of the meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003.
57. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003; 52:715-20.
58. Chan KS, Lai ST, Chu CM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003; 9:399-406.
59. Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361:1773-8.
60. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003; 361: 1615-7.
61. Ho JC, Ooi GC, Mok TY, et al. High dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003; 15:1449-56.
62. Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003; 348: 2034-5.
63. Wang H, Ding Y, Li X, et al. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med 2003; 349:507-8.
64. Tsang KW, Lam WK. Management of severe acute respiratory syndrome: the Hong Kong University experience. Am J Respir Crit Care Med 2003; 168:417-24.
65. Tsang O, Chau TN, Choi KW. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 2003; 9:1381-7.
66. Chan KS, Zheng JP, Mok YW, et al. SARS: prognosis, outcome and sequelae. Respirology 2003; 8:S36-S40.
67. Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 1997; 100:151-7.
68. Wong VW, Dai D, Wu AK, et al. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003; 9: 199-201.
69. Tsang K, Zhong NS. SARS: pharmacotherapy. Respirology 2003; 8: S25-30.